CUE-MARE A 7 TO 10 DAY INTRAVAGINAL PROGESTERONE TREATMENT FOR MARES

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

PROGESTERONE

Available from:

VETOQUINOL AUSTRALIA PTY LTD

INN (International Name):

progesterone(1.72g/Dv)

Pharmaceutical form:

ORAL BOLUS + INTRA VAGINAL/UTERINE

Composition:

PROGESTERONE STEROID-PROGESTIN Active 1.72 g

Units in package:

Singlepack

Class:

VM - Veterinary Medicine

Manufactured by:

VETOQUINOL

Therapeutic group:

HORSE MARE (FEMALE) | FEMALE HORSE

Therapeutic area:

ENDOCRINE SYSTEM

Therapeutic indications:

INDUCTION OF OVULATION

Product summary:

Poison schedule: 5; Withholding period: WHP: Nil ESI: Zero (0) days; Host/pest details: HORSE MARE (FEMALE): [INDUCTION OF OVULATION]; Poison schedule: 5; Withholding period: ; Host/pest details: HORSE MARE (FEMALE): [INDUCTION OF OVULATION]; The device is used in conjunction with human chorionic gonadotrophin &/or prostaglandin to deliver progesterone to achieve therapeutic effect for inducing cyclical ovarian activity in spring transitional mares.See Contraindications section on label

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                Cue-Mare A 7 to 10 day Intravaginal Progesterone Treatment for Mares
label and leaflet
62504/43237 one device
Version 05/09/11 page 1 of 4
_Main panel – primary pack label _
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
CUE-MARE
®
A 7 to 10 day intravaginal progesterone treatment for mares.
Each device contains 1.72 G PROGESTERONE
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
Contents: 1 Cue-Mare device for mares over 500 kg
This product is not tested on ponies
INDICATIONS:
The device is used in conjunction with human chorionic gonadotropin
and/or prostaglandin
to deliver progesterone to achieve therapeutic effect for inducing
cyclical ovarian activity in
spring transitional mares.
DIRECTIONS FOR USE
CONTRAINDICATIONS:
•
Contraindicated for use in animals in poor condition, poor health or
with abnormal
vaginas.
•
Contraindicated for use in small maiden mares when application
discomfort is
evident.
•
Contraindicated for use in mares known to be susceptible to
endometritis.
CRITICAL COMMENTS:
Cue-Mare consists of a “Wishbone” carrier body, two treatment pods
and a tail. A reusable
Applicator (available separately) is required for inserting the
device. A sterile lubricant is
required for inserting the devices and materials to hygienically
prepare the perineum of the
mare should also be on hand when inserting the device.
_Spring transitional anoestrus in mares_
Insert Cue-Mare into the vagina using an Applicator. Monitor the mare
twice daily for comfort
and retention. After 7 days check the mare for follicular activity,
withdraw the device if a
follicle of >35 mm exists, or at 10 days post insertion. The mare may
be injected with
prostaglandin at the time of device withdrawal. When a follicle of >35
mm is detected inject
the mare with 1500 IU human chorionic gonadotrophin and breed within
the next 36 hours.
Ovulation should be confirmed 2 days after breeding.
_REMOVE ANY DEVICE PRIOR TO SLAUGHTER. _
_ _
DOSAGE AND ADMINISTRATION
INSERTION PROCEDURE:
•
Wear dis
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                PRODUCT NAME: CUE-MARE®
PAGE: 1 OF 5
THIS REVISION ISSUED: OCTOBER, 2015
SAFETY DATA SHEET
Issued by: Vetoquinol Australia Pty Ltd
Phone: 1800 032 355
(BUSINESS HOURS)
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
VETOQUINOL AUSTRALIA PTY LTD
PHONE: 1800 032 355
(BUSINESS HOURS)
UNIT 302/2, 6-12 BORONIA ROAD, DA VINCI BUSINESS PARK,
FAX: 1800 648 460
BRISBANE AIRPORT, QLD 4008 CHEMICAL NATURE:
Each device contains 1.72g Progesterone in a suitable delivery
mechanism.
TRADE NAME:
CUE-MARE
®
PRODUCT USE:
Device used for inducing cyclical ovarian activity in spring
transitional mares.
CREATION DATE:
SEPTEMBER, 2011
THIS VERSION ISSUED:
OCTOBER, 2015
and is valid for 5 years from this date.
POISONS INFORMATION CENTRE: PHONE 13 1126 FROM ANYWHERE IN AUSTRALIA
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to Australian Dangerous Goods (ADG)
Code, IATA and IMDG/IMSBC criteria.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S2, S24. Keep out of reach of children. Avoid contact with skin.
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.
PREVENTION
P102: Keep out of reach of children.
P281: Use personal protective equipment as required.
RESPONSE
P337: If eye irritation persists: seek medical attention.
P352: Wash with plenty of soap and water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P370+P378: Not combustible. Use extinguishing media suited to burning
materials.
STORAGE
P410: Protect from sunlight.
P402+P404: Store in a dry place. Store in a closed container.
P403+P235: Store in a well-ventilated place. Keep cool.
DISPOSAL
P501: Dispose of contents and containers as specified on the
registered label.
EMERGENCY OVERVIEW P
                                
                                Read the complete document